Literature DB >> 6167248

Peripapillary subretinal neovascularization in presumed sarcoidosis.

E S Gragoudas, C D Regan.   

Abstract

Peripapillary subretinal neovascularization developed in both eyes of two young women with bilateral chronic granulomatous uveitis. Despite intensive medical therapy, central vision was lost in two eyes owing to disciform scarring that extended to the macula. The neovascularization in the other two eyes was treated successfully with argon laser photocoagulation. Neither of the patients had the clinical or roentgenographic findings typical of sarcoidosis. Both, however, showed elevated serum angiotensin-converting enzyme activity, which provides indirect evidence for the diagnosis of sarcoid uveitis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6167248     DOI: 10.1001/archopht.1981.03930020068003

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

Review 1.  Ocular involvement in sarcoidosis.

Authors:  A Rothova
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

2.  Regression of peripapillary choroidal neovascular membrane in a patient with sarcoidosis after oral steroid therapy.

Authors:  Samir S Shoughy; Mahmoud O Jaroudi; Khalid F Tabbara
Journal:  Saudi J Ophthalmol       Date:  2014-03-06

3.  Unusual clinical and histopathological findings in ocular sarcoidosis.

Authors:  K W Frank; H Weiss
Journal:  Br J Ophthalmol       Date:  1983-01       Impact factor: 4.638

4.  Subretinal neovascularization in the Vogt-Koyanagi-Harada syndrome.

Authors:  R R Ober; R E Smith; S J Ryan
Journal:  Int Ophthalmol       Date:  1983-06       Impact factor: 2.031

5.  Sarcoidosis: an expanding ophthalmic horizon.

Authors:  P Henkind
Journal:  J R Soc Med       Date:  1982-03       Impact factor: 18.000

6.  Peripapillary Choroidal Neovascular Membrane Secondary to Sarcoidosis-Related Panuveitis: Treatment with Aflibercept and Ranibizumab with a 50-month Follow-Up.

Authors:  Artemis Matsou; Maria Dermenoudi; Despina Tzetzi; Tryfon Rotsos; Olga Makri; Eleftherios Anastasopoulos; Chrysanthos Symeonidis
Journal:  Case Rep Ophthalmol       Date:  2021-04-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.